S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
pixel
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
pixel
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
pixel
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
pixel
Log in
NASDAQ:OTIC

Otonomy News Headlines

$2.59
-0.31 (-10.69 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.51
Now: $2.59
$2.90
50-Day Range
$2.88
MA: $4.69
$5.70
52-Week Range
$1.53
Now: $2.59
$6.98
Volume2.73 million shs
Average Volume1.41 million shs
Market Capitalization$125.15 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Headlines

Otonomy (NASDAQ OTIC) News Headlines Today

Source:
SourceHeadline
HC Wainwright Trims Otonomy (NASDAQ:OTIC) Target Price to $5.50HC Wainwright Trims Otonomy (NASDAQ:OTIC) Target Price to $5.50
marketbeat.com - February 23 at 10:13 AM
Otonomy, Inc. (NASDAQ:OTIC) Director Jay Lichter Sells 321,180 SharesOtonomy, Inc. (NASDAQ:OTIC) Director Jay Lichter Sells 321,180 Shares
americanbankingnews.com - March 3 at 9:24 PM
Otonomy (NASDAQ:OTIC)  Shares Down 10.7%  on Insider SellingOtonomy (NASDAQ:OTIC) Shares Down 10.7% on Insider Selling
americanbankingnews.com - March 3 at 6:51 PM
Jay Lichter Sells 173,700 Shares of Otonomy, Inc. (NASDAQ:OTIC) StockJay Lichter Sells 173,700 Shares of Otonomy, Inc. (NASDAQ:OTIC) Stock
americanbankingnews.com - March 2 at 9:40 PM
HC Wainwright Cuts Otonomy (NASDAQ:OTIC) Price Target to $5.50HC Wainwright Cuts Otonomy (NASDAQ:OTIC) Price Target to $5.50
americanbankingnews.com - March 1 at 11:29 AM
Looking Back at Bear Market 2020: The Timeless Lesson of One Year Ago Today - NasdaqLooking Back at Bear Market 2020: The Timeless Lesson of One Year Ago Today - Nasdaq
nasdaq.com - February 26 at 10:35 PM
Why Earnings Season Could Be Great for Switch (SWCH) - NasdaqWhy Earnings Season Could Be Great for Switch (SWCH) - Nasdaq
nasdaq.com - February 26 at 10:35 PM
Uptick in Revenues Drive Expeditors (EXPD), High Costs Ail - NasdaqUptick in Revenues Drive Expeditors (EXPD), High Costs Ail - Nasdaq
nasdaq.com - February 26 at 12:34 PM
Are Options Traders Betting on a Big Move in Otonomy (OTIC) Stock? - NasdaqAre Options Traders Betting on a Big Move in Otonomy (OTIC) Stock? - Nasdaq
nasdaq.com - February 26 at 12:34 PM
Insider Selling: Otonomy, Inc. (NASDAQ:OTIC) Director Sells 268,118 Shares of StockInsider Selling: Otonomy, Inc. (NASDAQ:OTIC) Director Sells 268,118 Shares of Stock
americanbankingnews.com - February 26 at 12:42 AM
Insider Selling: Otonomy, Inc. (NASDAQ:OTIC) Director Sells 311,100 Shares of StockInsider Selling: Otonomy, Inc. (NASDAQ:OTIC) Director Sells 311,100 Shares of Stock
americanbankingnews.com - February 26 at 12:42 AM
Otonomy to Participate in Three Upcoming Investor Conferences - Yahoo FinanceOtonomy to Participate in Three Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - February 25 at 10:26 AM
Otonomy to Participate in Three Upcoming Investor ConferencesOtonomy to Participate in Three Upcoming Investor Conferences
finance.yahoo.com - February 25 at 10:26 AM
Otonomy (NASDAQ:OTIC) PT Lowered to $5.50Otonomy (NASDAQ:OTIC) PT Lowered to $5.50
americanbankingnews.com - February 23 at 10:14 AM
BCLI Slips On FDA Feedback, OTIC Plunges As Ménières Disease Trial Fails, CLNN On Watch - NasdaqBCLI Slips On FDA Feedback, OTIC Plunges As Ménière's Disease Trial Fails, CLNN On Watch - Nasdaq
nasdaq.com - February 23 at 9:13 AM
ROCE Insights For Otonomy - Yahoo FinanceROCE Insights For Otonomy - Yahoo Finance
finance.yahoo.com - February 23 at 12:02 AM
Otonomy stock loses half its value after disappointing trial results of vertigo treatment - MarketWatchOtonomy stock loses half its value after disappointing trial results of vertigo treatment - MarketWatch
marketwatch.com - February 23 at 12:02 AM
Piper Sandler Lowers Otonomy (NASDAQ:OTIC) Price Target to $5.00Piper Sandler Lowers Otonomy (NASDAQ:OTIC) Price Target to $5.00
americanbankingnews.com - February 22 at 3:46 PM
Celsion, Citius Pharmaceuticals leads healthcare gainers - Seeking AlphaCelsion, Citius Pharmaceuticals leads healthcare gainers - Seeking Alpha
seekingalpha.com - February 22 at 1:56 PM
ROCE Insights For Otonomy - BenzingaROCE Insights For Otonomy - Benzinga
benzinga.com - February 22 at 1:56 PM
ROCE Insights For OtonomyROCE Insights For Otonomy
finance.yahoo.com - February 22 at 1:56 PM
Otonomy (NASDAQ:OTIC) Shares Gap Down to $5.39Otonomy (NASDAQ:OTIC) Shares Gap Down to $5.39
americanbankingnews.com - February 22 at 9:45 AM
Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménières Disease - GlobeNewswireOtonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease - GlobeNewswire
globenewswire.com - February 22 at 8:56 AM
Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménières DiseaseOtonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease
finance.yahoo.com - February 22 at 8:56 AM
Otonomy stock loses half its value after disappointing trial results of vertigo treatmentOtonomy stock loses half its value after disappointing trial results of vertigo treatment
finance.yahoo.com - February 22 at 8:56 AM
Otonomy (NASDAQ:OTIC) Trading Up 8.5%Otonomy (NASDAQ:OTIC) Trading Up 8.5%
americanbankingnews.com - February 17 at 7:08 PM
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting - GlobeNewswireOtonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting - GlobeNewswire
globenewswire.com - February 17 at 8:38 AM
Genentechs Faricimab Data Show Promise Of New Treatment For Two Common Causes Of Blindness - NasdaqGenentech's Faricimab Data Show Promise Of New Treatment For Two Common Causes Of Blindness - Nasdaq
nasdaq.com - February 12 at 5:09 PM
Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateOtonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
marketwatch.com - February 12 at 12:08 PM
Otonomy (NASDAQ:OTIC) Releases  Earnings Results, Beats Expectations By $0.02 EPSOtonomy (NASDAQ:OTIC) Releases Earnings Results, Beats Expectations By $0.02 EPS
americanbankingnews.com - February 12 at 10:35 AM
Otonomy (OTIC) Q4 2020 Earnings Call Transcript - The Motley FoolOtonomy (OTIC) Q4 2020 Earnings Call Transcript - The Motley Fool
fool.com - February 12 at 7:07 AM
Otonomy, Inc. (OTIC) CEO David Weber on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaOtonomy, Inc. (OTIC) CEO David Weber on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 12 at 1:48 AM
Otonomy (OTIC) Q4 2020 Earnings Call TranscriptOtonomy (OTIC) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 12 at 1:48 AM
Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and  Provides Corporate UpdateOtonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - February 11 at 8:47 PM
Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update - Yahoo FinanceOtonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update - Yahoo Finance
finance.yahoo.com - February 4 at 7:44 AM
Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate UpdateOtonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - February 4 at 7:44 AM
Otonomy IncOtonomy Inc
bloomberg.com - January 23 at 6:46 PM
Otonomy And Its Efforts At Resurrecting Itself - Seeking AlphaOtonomy And Its Efforts At Resurrecting Itself - Seeking Alpha
seekingalpha.com - January 12 at 7:27 PM
Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference - Yahoo FinanceOtonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference - Yahoo Finance
finance.yahoo.com - January 5 at 8:53 AM
Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual ConferenceOtonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference
finance.yahoo.com - January 5 at 8:52 AM
Thinking about buying stock in Evolus, Rite Aid, Roku, Marathon Patent Group, or Otonomy? - PRNewswireThinking about buying stock in Evolus, Rite Aid, Roku, Marathon Patent Group, or Otonomy? - PRNewswire
prnewswire.com - December 17 at 9:17 AM
Otonomys OTO-413 shows clinical benefit in hearing loss study - Seeking AlphaOtonomy's OTO-413 shows clinical benefit in hearing loss study - Seeking Alpha
seekingalpha.com - December 17 at 9:17 AM
Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing LossOtonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing Loss
finance.yahoo.com - December 17 at 9:17 AM
Is OTIC A Good Stock To Buy Now? - Yahoo FinanceIs OTIC A Good Stock To Buy Now? - Yahoo Finance
finance.yahoo.com - December 16 at 12:40 AM
Is OTIC A Good Stock To Buy Now?Is OTIC A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 12:40 AM
Is the Options Market Predicting a Spike in Lineage Cell Therapeutics (LCTX) Stock? - NasdaqIs the Options Market Predicting a Spike in Lineage Cell Therapeutics (LCTX) Stock? - Nasdaq
nasdaq.com - December 14 at 6:09 PM
Implied Volatility Surging for Energy Fuels (UUUU) Stock Options - NasdaqImplied Volatility Surging for Energy Fuels (UUUU) Stock Options - Nasdaq
nasdaq.com - December 14 at 12:48 PM
JetBlue (JBLU) Initiates Service to Guyana From New York - NasdaqJetBlue (JBLU) Initiates Service to Guyana From New York - Nasdaq
nasdaq.com - December 14 at 12:48 PM
Otonomy (OTIC) Looks Good: Stock Adds 5% in Session - Yahoo FinanceOtonomy (OTIC) Looks Good: Stock Adds 5% in Session - Yahoo Finance
finance.yahoo.com - December 14 at 12:48 PM
Otonomy (OTIC) Looks Good: Stock Adds 5% in SessionOtonomy (OTIC) Looks Good: Stock Adds 5% in Session
finance.yahoo.com - December 14 at 12:48 PM
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street - Yahoo FinanceThe Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street - Yahoo Finance
finance.yahoo.com - December 11 at 12:44 PM
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.